The global antiseptics and disinfectants market size was valued at USD 34.9 billion in 2021 and is expected to witness a compound annual growth rate (CAGR) of 10.1% from 2022 to 2030. An increase in the prevalence of diseases such as typhoid, cholera, hepatitis A, food poisoning, and dengue, primarily due to lack of home cleanliness, is one of the major factors expected to drive market growth. For instance, as per a report published by WHO in 2022, Over the last two decades, the number of dengue cases reported to WHO has surged by more than 8-fold, from 505,430 cases in 2000 to over 2.4 million in 2010, and 5.2 million in 2019. Such diseases are mainly caused by viruses, bacteria, and germs, which thrive in unhealthy home environments and unhygienic toilets, latrines, and kitchens.
The application of antiseptic and disinfectant solutions is, therefore, an essential requirement to maintain home cleanliness. Such solutions prevent the growth of harmful bacteria and viruses, reducing the chance of acquiring these diseases. Hence, an increase in awareness about home cleanliness is anticipated to propel the market for antiseptics and disinfectants over the forecast period. The current COVID-19 outbreak is expected to have a substantial impact on the market for antiseptics and disinfectants. The COVID-19 pandemic, as well as an overall increase in hospital admissions around the world, has boosted the demand for medical disposables.
To meet the rising worldwide demand for cleaning, deodorizing, and disinfecting in high-traffic facilities, including office buildings, hotels, schools, nursing homes, and hospitals due to the COVID-19 outbreak, the WHO has urged industry and governments to expand the production of antiseptics and disinfectants. For instance, according to the German Federal Statistical Office, in 2020, demand for disinfectants has risen in the aftermath of the coronavirus pandemic, for example, 80% more hygiene products were produced in Germany between January and September 2020 than in the same period last year. Additionally, antiseptics and disinfectants manufacturing companies use unique and new technologies to design, produce, and sell products to diverse end customers based on the amount of protection required for distinct job risks.
For instance, in November 2020the Environmental Protection Agency (EPA) of the U.S. approved 3M’s disinfectant TB Quat for SARS-CoV-2 which is a ready-to-use cleaner. Third-party lab testing of 3M’s disinfectant TB Quat ready-to-use cleaner on hard, non-porous surfaces with a 60-second contact period proved the disinfectant’s effectiveness against the virus. As a result, market growth is expected to accelerate in the near future. Moreover, in January 2021, 5 SC Johnson home cleaning products have been added to Health Canada’s list of effective disinfectants for use against SARS-CoV-2. SC Johnson has approved the following disinfectants to kill SARS-CoV-2, the virus that causes COVID-19 symptoms like scrubbing bubbles. They come in a variety of fragrances. Thus, due to the past and ongoing advancements through various companies, the positive impact of the COVID-19 pandemic was seen on the market for antiseptics and disinfectants.
The increasing incidence of HAIs due to lack of precaution and sanitation is one of the leading factors contributing to the growth of the market for antiseptics and disinfectants. For instance, as per the Healthcare-Associated Infections in 2020, every year, around one in every 25 hospital patients acquires at least one HAI. Antiseptics and disinfectants offer general anti-contamination protection and can help reduce the incidence of HAIs. They can also keep bacterial and other microbial diseases from entering the body of a patient. Over the forecast period, these factors are expected to drive market expansion. Gastrointestinal (GI) endoscopy allows doctors to view the inner lining of the digestive tract. The endoscope can enable the diagnosis and treatment of several GI diseases. A GI endoscopy can be performed either in inpatient or outpatient settings.
However, it can lead to several complications if the endoscopes are not properly reprocessed. To reduce the danger of spreading environmental or patient-borne pathogens between patients, endoscopes must be reprocessed according to infection-control protocols. In such cases, the application of proper disinfectant and antiseptics solutions is essential to prevent the transmission of infections. Moreover, increasing demand for endoscopy is expected to increase the risk of getting HAIs. For instance, as per BMJ Publishing Group Ltd. and the British Society of Gastroenterology in 2018, the need for gastrointestinal endoscopy for colon cancer screening in symptomatic patients has skyrocketed. Over the last five years, demand in several U.K. cities has virtually doubled. Therefore, increasing use of endoscope reprocesses and surgical units are expected to propel the market for antiseptics and disinfectants over the forecast period.
The growing number of surgeries globally is also a key factor expected to drive the market growth over the forecast period. For instance, as per the Mölnlycke Health Care AB, 70.00 million surgical procedures are performed every year in Europe. Similarly, according to the Healthcare Cost and Utilization Project (HCUP), in 2018, more than 9,942,000 surgeries were performed in the U.S. within ambulatory care settings. In the case of surgeries, the use of antiseptics and disinfectant products is one of the essential requirements in hospitals, clinics, and ambulatory surgery centers. Therefore, such instances are expected to drive the market for antiseptics and disinfectants.
Based on type, the quaternary ammonium compounds segment held the largest revenue share of 31.4% in 2021 and is expected to witness considerable growth over the forecast period. Quaternary ammonium compounds are widely used as surface disinfectants in hospitals and laboratories. These compounds aid in controlling the spread of healthcare-associated infections in hospitals and clinics. In addition, it is also used for disinfecting medical equipment that comes into direct contact with skin. The rising incidence of hospital-acquired infections across the globe is likely to positively impact the segment growth. For instance, as per WHO, every year, 7 out of every 100 hospitalized patients in industrialized nations and 10 out of every 100 hospitalized patients in underdeveloped countries acquire at least one healthcare-associated infection.
The enzyme segment is anticipated to witness the fastest growth rate over the forecast period. Generally, enzyme-based antiseptics and disinfectants are used to control odors that are created by chemical processes. It is also commonly used in research facilities for cleaning enzyme-based or catalyst-based products. It’s used to clean testing kits in hospitals and clinics. The demand for these items is predicted to rise as the number of research facilities grows as a result of increased R&D spending around the world. For instance, as per Congressional Research Service, globally, total global R&D spending has more than tripled in current dollars since 2000, rising from $677 billion to $2.2 trillion in 2019, which is expected to boost the number of research laboratories owing to which segment is anticipated to grow over the forecast period.
Report Coverage & Deliverables
PDF report & online dashboard will help you understand:
- Competitive benchmarking
- Historical data & forecasts
- Company revenue shares
- Regional opportunities
- Latest trends & dynamics
The medical device disinfectants segment held the largest revenue share of 45.7% in 2021. Medical device disinfectants are generally used for reprocessing surgical units and endoscopes. Glutaraldehyde, phenol/phenate, hydrogen peroxide, and peracetic acid are some of the disinfectants used for reprocessing/disinfection of medical devices. Proper reprocessing of medical devices and endoscopes is essential as they transmit infection from one patient to another due to direct contact with skin. The increasing number of surgical procedures across the globe may be considered to be one of the major reasons for driving the segment over the forecast period.
The enzymatic cleaners segment is anticipated to witness the fastest growth rate over the forecast period. Enzymatic cleaners are more efficient on bacterial surfaces and are commonly used to avoid odor. It’s commonly used to disinfect testing kits and surgical equipment in clinics and hospitals. The number of surgical procedures and the amount of hospital-acquired illnesses are two important variables driving the industry. Non-pathogenic beneficial microorganisms in enzyme cleaners are effective at displacing disease-causing germs without causing any side effects. The residue of certain antiseptics and disinfectants can sometimes cause harm to humans. In such cases, enzymatic cleaners are used. Hence, the segment is anticipated to grow over the forecast period.
Sales Channel Insights
The B2B segment dominated the market for antiseptics and disinfectants and held the largest revenue share of 65.1% in 2021. In the B2B sales channel, companies directly sell their products to businesses and not to consumers. B2B sales channels usually have longer sales cycles and higher-order values. B2B sales channel is expected to witness a low growth rate during the forecast period owing to entry barriers in the B2B business, which include a lack of investment to develop technologically advanced products and challenges pertaining to coordinating with various vendors. Medical device disinfectants, enzymatic cleaners, and surface disinfectants are major antiseptics and disinfectants marketed under the B2B sales channel. Hospitals, clinics, healthcare providers, and suppliers are major end-users of the B2B sales channel.
The FMCG distribution channel comprises three major entities: agents, facilitators, and merchants. Agents generally generate sales by promoting the products of the company. Agents can be a member of the company or independent individuals. Facilitators are generally involved in the transportation of manufactured goods from one place to another. Warehouse owners, logistic services, and independent types are included under the facilitator’s category. Wholesalers and retailers are generally categorized under the merchant’s category. Consumers generally purchase FMCG products directly from retailers and wholesalers. Hand sanitizers, antiseptic topical creams, antiseptic washes, and antiseptics wipes are categorized under the FMCG product line. 3M, Lifebuoy, Dettol, and Purell are some of the notable brands of hand sanitizers. Nufree Finipil Pro Elec Antiseptic Cream, Tea Tree Therapy Antiseptic Cream, and Neosporin are some of the notable antiseptics topical cream brands marketed as FMCG products.
The hospital segment dominated the market for antiseptics and disinfectants and accounted for a revenue share of 46.2% in 2021. The increasing incidence of hospital-acquired infections across the globe is one of the major reasons for segment growth over the forecast period. For instance, as per CDC, every day, around 1 out of every 31 hospital patients contracts a hospital-acquired infection. The use of appropriate disinfectants and antiseptics is critical in reducing the spread of illnesses. Furthermore, increasing healthcare expenditure in developed and developing countries might increase the number of hospitals owing to which demand for antiseptics and disinfectants is also expected to increase. For instance, as per Eurostat, Germany, and France, had the highest healthcare expenditure (around 11.8%) in GDP in 2019. Thus, such factors are expected to propel segment growth over the forecast period.
Over the forecast period, the increasing number of surgical procedures and hospitals will be important drivers of the segment’s growth. To maintain a healthy atmosphere in the clinic, basic sanitation and hygiene are required. Additionally, an increase in the number of hospital-acquired infections may increase the demand for antiseptics and disinfectants. Therefore, the segment is expected to grow over the forecast period.
North America dominated the antiseptics and disinfectants market and accounted for a revenue share of around 34.4% in 2021. The growing number of healthcare personnel conducted in North America and the increasing number of surgeries are the factors predicted to increase the demand for disinfectants and antiseptics in the region. Antiseptic and disinfectant solutions are necessary for surgical procedures and research because they limit the danger of contamination and infection transmission from one patient to the next. Furthermore, as doctors encourage the use of disinfection treatments, an increase in the number of hospital-acquired illnesses may drive up the demand for such solutions. As a result, these factors are projected to drive market expansion throughout the forecast period.
The increasing incidence of healthcare-associated infections, food poisoning, cholera, and typhoid fever is a major factor driving the market over the forecast period. In addition, rising awareness about home cleanliness among people is likely to positively impact the market growth. Furthermore, major players are also making efforts to enter untapped markets in the Asia Pacific region, thereby expanding the market scope.
Key Companies & Market Share Insights
Key players are involved in adopting strategies such as mergers and acquisitions, partnerships, and launching new products to strengthen their foothold in the market for antiseptics and disinfectants. Key players are entering into mergers and acquisitions to increase their market share and customer base across the globe. For instance, in January 2021, Cantel Medical Corporation was acquired by STERIS through a subsidiary in the U.S. Cantel is a global provider of infection prevention services and products, with a focus on dental and endoscopic customers. Thus, this in turn is projected to boost the market growth. Moreover, in June 2018, Fortive Corporation made a binding bid to buy Johnson & Johnson’s Advanced Sterilization Products business, which is part of Ethicon, Inc. Some of the prominent players in the antiseptics and disinfectants market include:
- Reckitt Benckiser
- Steris Plc
- Kimberly-Clark Corporation
- Bio-Cide International, Inc.
- Cardinal Health
- Johnson & Johnson
Antiseptics And Disinfectants Market Report Scope
|Market size value in 2022||USD 29.1 billion|
|Revenue forecast in 2030||USD 63.1 billion|
|Growth Rate||CAGR of 10.1% from 2022 to 2030|
|Base year for estimation||2021|
|Historical data||2017 – 2021|
|Forecast period||2022 – 2030|
|Quantitative units||Revenue in USD Million and CAGR from 2022 to 2030|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Segments covered||Type, product, sales channel, end-use, region|
|Regional scope||North America; Europe; Asia Pacific; Latin America; MEA|
|Country scope||U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Australia; South Korea; Brazil; Mexico; Colombia; Argentina; South Africa; Saudi Arabia; UAE|
|Key companies profiled||3M; Reckitt Benckiser; STERIS plc; Kimberly; Clark Corporation; Bio-Cide International; Cardinal Health; BD; Johnson & Johnson|
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For the purpose of this study, Grand View Research has segmented the global antiseptics and disinfectants market report on the basis of type, product, sales channel, end-use, and region:
- Type Outlook (Revenue, USD Million, 2017 – 2030)
- Quaternary Ammonium Compounds
- Chlorine Compounds
- Alcohols & Aldehyde Products
- Product Outlook (Revenue, USD Million, 2017 – 2030)
- Enzymatic Cleaners
- Medical Device Disinfectants
- Surface Disinfectants
- Sales Channel Outlook (Revenue, USD Million, 2017 – 2030)
- End-use Outlook (Revenue, USD Million, 2017 – 2030)
- Regional Outlook (Revenue, USD Million, 2017 – 2030)
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- North America